Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
Actual shortage: | 255 (10%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2413 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (9%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-10-19 | 2024-04-11 | 207548 |
TEVA-TADALAFIL | 20MG | TABLET | Resolved | 2023-10-19 | 2024-03-21 | 207551 |
TEVA-SPIRONOLACTONE/HCTZ | 50MG 50MG | TABLET | Resolved | 2023-10-26 | 2023-11-09 | 208251 |
TEVA-BETAHISTINE | 8MG | TABLET | Resolved | 2023-10-26 | 2023-11-23 | 208254 |
TEVA-BETAHISTINE | 24MG | TABLET | Resolved | 2023-10-26 | 2023-11-03 | 208257 |
ACT PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2023-10-26 | 2024-01-11 | 208260 |
TEVA-FLUVOXAMINE | 100MG | TABLET | Resolved | 2023-11-03 | 2024-05-09 | 209108 |
TEVA-FLUVASTATIN | 20MG | CAPSULE | Resolved | 2023-11-03 | 2024-04-25 | 209111 |
TEVA-TOPISONE | 0.05% | CREAM | Resolved | 2023-11-03 | 2023-12-14 | 209116 |
TEVA-TOPISONE | 0.05% | LOTION | Resolved | 2023-11-03 | 2023-12-14 | 209119 |
TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Resolved | 2023-11-03 | 2024-03-07 | 209122 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2023-11-03 | 2024-01-25 | 209125 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2023-11-03 | 2023-11-23 | 209130 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2023-11-03 | 2024-01-25 | 209133 |
TEVA-CEPHALEXIN | 250MG | TABLET | Resolved | 2023-11-03 | 2024-04-18 | 209136 |
TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2023-11-03 | 2023-12-14 | 209139 |
TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2023-11-03 | 2023-12-14 | 209142 |
TEVA-BUDESONIDE | 0.125MG | SUSPENSION | Resolved | 2023-11-03 | 2024-01-19 | 209145 |
TEVA-NAPROXEN | 375MG | TABLET | Resolved | 2023-11-09 | 2024-01-11 | 209661 |
TEVA-ATOMOXETINE | 10MG | CAPSULE | Resolved | 2023-11-09 | 2023-12-14 | 209669 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64601 |
TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64606 |
TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64609 |
TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64612 |
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64846 |
TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64849 |
RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64855 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64858 |